Horizon Surgical Systems announced that it closed a $30 million Series A financing to support its novel surgical robotic platform.
Malibu, California-based Horizon aims to advance microsurgery with automated, AI-enabled robotic technology. It plans to use proceeds to advance the development of its Polaris technology platform for eye surgery. Funds could help progress to first-in-human studies and further build out the company’s team.
The company said its Polaris system leverages state-of-the-art robotics, advanced medical imaging and AI. It aims to extend the capabilities of surgeons beyond their current limitations.
ExSight Ventures and a major corporate investor led the financing round. Main Street Advisors and the University of California (UC Investments), among others, also participated. In connection with the financing, Horizon added ExSight’s Dr. Firas Rahhal and investor William Link to its board.
“We at Horizon are proud to have the strong backing of ExSight, other key investors including Main Street Advisors and University of California, and a major corporate investor, in our Series A financing round,” said Dr. Jean-Pierre Hubschman, Horizon founder and CEO. “Both our team and investors recognize that our Polaris system is poised to capitalize on the next era in surgical robotics, enhancing the surgeon’s natural capabilities with state-of-the-art augmented visualization and precision robotic control.
As artificial intelligence continues to advance surgical robotics, I believe it will unlock unprecedented surgical assistance capabilities within the Polaris platform, driving unmatched accuracy, efficiency, and outcomes in the operating room. With this firm vote of confidence from our investors and leadership, Horizon is moving swiftly toward our first-in-human study.”
